What blood investigations are needed for a child with failure to thrive and chronic diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Investigations for Child with Failure to Thrive and Chronic Diarrhea

Begin with a focused panel of screening blood tests to exclude common treatable causes including celiac disease, anemia, and malabsorption, while avoiding extensive laboratory evaluation unless specific clinical features suggest organic disease. 1, 2

Initial Screening Blood Tests (First-Line)

Complete Blood Count (CBC) with Differential

  • Assess for anemia (iron deficiency from malabsorption or chronic blood loss) 1
  • Evaluate for thrombocytopenia and leukopenia (seen in storage diseases like ASMD) 1
  • Check for eosinophilia (suggests food protein-induced enterocolitis syndrome or parasitic infection) 1
  • Identify thrombocytosis (reported in 65% of acute FPIES cases) 1

Celiac Disease Serology

  • Tissue transglutaminase IgA (TG2-IgA) is the primary screening test with 98-100% accuracy when malabsorption symptoms including failure-to-thrive are present 1
  • Total IgA level must be measured simultaneously to exclude IgA deficiency (which would cause false-negative TG2-IgA) 1
  • If IgA deficient, obtain IgG-based tests (deamidated gliadin peptide IgG or TG2-IgG) 1

Basic Metabolic Panel

  • Serum sodium and electrolytes to detect hypernatremic dehydration or metabolic acidosis 1
  • Blood glucose to exclude hyperglycemia with osmotic diuresis 1

Liver Function Tests

  • Elevated transaminases occur in celiac disease, ASMD, and other storage disorders 1
  • Albumin level assesses for hypoalbuminemia from protein-losing enteropathy 1

Additional First-Line Tests Based on Clinical Context

  • Thyroid function tests (TSH, free T4) if autoimmune thyroid disease suspected, as celiac disease co-occurs with autoimmune conditions 1
  • Fasting lipid panel if hepatosplenomegaly present (dyslipidemia with decreased HDL and increased triglycerides suggests ASMD) 1

Second-Line Blood Tests (When First-Line Normal but Symptoms Persist)

Stool Studies Should Precede Additional Blood Work

  • Stool culture for bacterial pathogens (Campylobacter, Salmonella, Shigella) as chronic Campylobacter can cause failure to thrive 3
  • Fecal calprotectin to exclude inflammatory bowel disease 1
  • Fecal elastase for pancreatic insufficiency 1

If Malabsorption Suspected Despite Normal Initial Tests

  • Fat-soluble vitamin levels (A, D, E, K) indicate fat malabsorption 1
  • Prothrombin time/INR (vitamin K deficiency from malabsorption) 1
  • Iron studies, ferritin, B12, and folate (deficiencies suggest small bowel disease) 1

If Storage Disease or Metabolic Disorder Suspected

  • Enzyme assay for acid sphingomyelinase (ASM) activity if hepatosplenomegaly, dyslipidemia, and chronic diarrhea present 1
  • Consider genetic testing early if congenital diarrhea and enteropathy (CODE) suspected, as whole-exome sequencing can expedite diagnosis 4

Critical Clinical Caveats

Avoid Extensive Laboratory Evaluation in Most Cases

  • Laboratory testing yields positive results in only 3.2% of children with failure to thrive in gastroenterology clinics 2
  • 89% of children with failure to thrive have nonorganic etiologies requiring behavioral and nutritional interventions rather than extensive testing 2
  • The majority of children (56.4%) undergo laboratory evaluation, but this should be judiciously performed based on specific clinical indicators 2

Red Flags Requiring Expanded Workup

  • Bloody diarrhea with mucus suggests invasive bacterial infection requiring immediate stool culture 5, 6
  • Hepatosplenomegaly with chronic diarrhea at 6 months warrants evaluation for storage diseases (ASMD) with enzyme assays and genetic testing 1
  • Persistent symptoms despite adequate caloric intake and behavioral interventions justify second-line testing 2
  • Eastern European Jewish ancestry with hepatosplenomegaly should prompt early ASM enzyme assay 1

Age-Specific Considerations

  • Infants under 2 years with chronic diarrhea: prioritize celiac serology, stool studies for infection, and consider food protein-induced enterocolitis syndrome 1, 4
  • Normal infants may shift to lower growth percentiles in first 2 years without representing true failure to thrive 7
  • Premature infants and those with Down syndrome follow different growth patterns and should not be diagnosed with failure to thrive based on standard curves alone 7

When to Consider Genetic Testing Early

  • Diarrhea from birth with severe malabsorption unresponsive to dietary modifications suggests congenital enteropathy requiring whole-exome or genome sequencing 4, 8
  • Consanguineous parents or affected siblings increase likelihood of genetic disorder 8
  • Villus atrophy with crypt hypoplasia on biopsy without inflammatory infiltrate suggests familial enteropathy 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Failure to Thrive: A Prospective Study in a Pediatric Gastroenterology Clinic.

Journal of pediatric gastroenterology and nutrition, 2016

Research

Chronic diarrhea and failure to thrive in an infant with Campylobacter jejuni.

Journal of pediatric gastroenterology and nutrition, 1984

Guideline

Management of Gastroenteritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Diarrhea with Mucus and Blood Streak in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Failure to thrive.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.